Interleukin-5 Antagonists [MoA] - N0000191871

Pharmacologic Code	N0000191871
Pharmacologic Name	Interleukin-5 Antagonists
Pharmacologic Uses	interleukin-5 antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Interleukin-5 Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0173-0881	Nucala	Non-Proprietary Name: Mepolizumab	Injection, Powder, For Solution	Subcutaneous	Glaxosmithkline Llc	ACTIVE
	0173-0892	Nucala	Non-Proprietary Name: Mepolizumab	Injection, Solution	Subcutaneous	Glaxosmithkline Llc	ACTIVE
	0173-0904	Nucala	Non-Proprietary Name: Mepolizumab	Injection, Solution	Subcutaneous	Glaxosmithkline Llc	ACTIVE
	59310-610	Cinqair	Non-Proprietary Name: Reslizumab	Injection, Solution, Concentrate	Intravenous	Teva Respiratory, Llc	ACTIVE